Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

How Many of the Biopsy Decisions Taken at Inexperienced Breast Radiology Units Were Correct?

Demircioğlu Ö, Uluer M, Arıbal E.

J Breast Health. 2017 Jan 1;13(1):23-26. doi: 10.5152/tjbh.2016.2962. eCollection 2017 Jan.

3.

Psychological Outcomes After a False Positive Mammogram: Preliminary Evidence for Ethnic Differences Across Time.

Molina Y, Beresford SA, Thompson B.

J Racial Ethn Health Disparities. 2017 Apr;4(2):123-133. doi: 10.1007/s40615-016-0209-0. Epub 2016 Feb 19.

PMID:
26896036
4.

Benefits and harms of mammography screening.

Løberg M, Lousdal ML, Bretthauer M, Kalager M.

Breast Cancer Res. 2015 May 1;17:63. doi: 10.1186/s13058-015-0525-z. Review.

5.

Is there excess mortality in women screened with mammography: a meta-analysis of non-breast cancer mortality.

Erpeldinger S, Fayolle L, Boussageon R, Flori M, Lainé X, Moreau A, Gueyffier F.

Trials. 2013 Nov 5;14:368. doi: 10.1186/1745-6215-14-368. Review.

6.

HER2/neu protein expression and fine needle breast aspiration from Argentinean patients with non-palpable breast lesions.

Domínguez WG, Nardi H, Montero H, Vincent E, Corte MM, Balogh GA.

Exp Ther Med. 2010 Jul;1(4):597-602. Epub 2010 Jul 1.

7.

Immunophenotyping invasive breast cancer: paving the road for molecular imaging.

Vermeulen JF, van Brussel AS, van der Groep P, Morsink FH, Bult P, van der Wall E, van Diest PJ.

BMC Cancer. 2012 Jun 13;12:240. doi: 10.1186/1471-2407-12-240.

8.

False-positive results in the randomized controlled trial of mammographic screening from age 40 ("Age" trial).

Johns LE, Moss SM; Age Trial Management Group.

Cancer Epidemiol Biomarkers Prev. 2010 Nov;19(11):2758-64. doi: 10.1158/1055-9965.EPI-10-0623. Epub 2010 Sep 13.

9.

Cost of breast-related care in the year following false positive screening mammograms.

Chubak J, Boudreau DM, Fishman PA, Elmore JG.

Med Care. 2010 Sep;48(9):815-20. doi: 10.1097/MLR.0b013e3181e57918.

10.

Breast imaging in the new era.

Planche K, Vinnicombe S.

Cancer Imaging. 2004 Jan 12;4(2):39-50. doi: 10.1102/1470-7330.2003.0033.

11.
12.

The impact of a suspicious prostate biopsy on patients' psychological, socio-behavioral, and medical care outcomes.

Fowler FJ Jr, Barry MJ, Walker-Corkery B, Caubet JF, Bates DW, Lee JM, Hauser A, McNaughton-Collins M.

J Gen Intern Med. 2006 Jul;21(7):715-21.

13.
14.

Hormone replacement therapy and false positive recall in the Million Women Study: patterns of use, hormonal constituents and consistency of effect.

Banks E, Reeves G, Beral V, Bull D, Crossley B, Simmonds M, Hilton E, Bailey S, Barrett N, Briers P, English R, Jackson A, Kutt E, Lavelle J, Rockall L, Wallis MG, Wilson M, Patnick J.

Breast Cancer Res. 2006;8(1):R8. Epub 2005 Dec 23.

16.

Should women under 50 be screened for breast cancer?

Moss S.

Br J Cancer. 2004 Aug 2;91(3):413-7. Review.

17.

Impact of false-positive mammography on subsequent screening attendance and risk of cancer.

McCann J, Stockton D, Godward S.

Breast Cancer Res. 2002;4(5):R11. Epub 2002 Jul 17.

18.

Equity in prevention and health care.

Lorant V, Boland B, Humblet P, Deliège D.

J Epidemiol Community Health. 2002 Jul;56(7):510-6.

19.

US women's attitudes to false-positive mammography results and detection of ductal carcinoma in situ: cross-sectional survey.

Schwartz LM, Woloshin S, Sox HC, Fischhoff B, Welch HG.

West J Med. 2000 Nov;173(5):307-12.

20.

US women's attitudes to false positive mammography results and detection of ductal carcinoma in situ: cross sectional survey.

Schwartz LM, Woloshin S, Sox HC, Fischhoff B, Welch HG.

BMJ. 2000 Jun 17;320(7250):1635-40.

Supplemental Content

Support Center